Prof. Dr. med. MSc Mira Katan

Rohner, R., Kneihsl, M., Goeldlin, M. B., Hakim, A., Branca, M., Abend, S., Valenzuela Pinilla, W., Fenzl, S., Rezny-Kasprzak, B., Strbian, D., Trelle, S., Paciaroni, M., Thomalla, G., Michel, P., Nedeltchev, K., Gattringer, T., Sandset, E. C., Bonati, L., Aguiar de Sousa, D., et al. (2024). Early Versus Late Initiation of Direct Oral Anticoagulants After Ischemic Stroke in People With Atrial Fibrillation and Hemorrhagic Transformation: Prespecified Subanalysis of the Randomized-controlled ELAN Trial [Journal-article]. Circulation. https://doi.org/10.1161/circulationaha.124.069324

van Niftrik, Christiaan H.B., Sebök, Martina, Germans, Menno R., Halter, Matthias, Pokorny, Thomas, Stumpo, Vittorio, Bellomo, Jacopo, Piccirelli, Marco, Pangalu, Athina, Katan, Mira, Wegener, Susanne, Tymianski, Michael, Kulcsár, Zsolt, Luft, Andreas R., Fisher, Joseph A., Mikulis, David J., Regli, Luca, & Fierstra, Jorn. (2024). Increased Risk of Recurrent Stroke in Symptomatic Large Vessel Disease With Impaired BOLD Cerebrovascular Reactivity [Journal-article]. Stroke. https://doi.org/10.1161/strokeaha.123.044259

Dittrich, Tolga D, von Streng, Tennessee, Toebak, Anna M, Zietz, Annaelle, Wagner, Benjamin, Hänsel, Martin, Sutter, Raoul, Katan, Mira, Peters, Nils, Michels, Lars, Kulcsár, Zsolt, Karwacki, Grzegorz M, Pileggi, Marco, Cereda, Carlo W, Wegener, Susanne, Bonati, Leo H, Psychogios, Marios, & De Marchis, Gian Marco. (2024). Absent leptomeningeal collateralization is associated with greatest benefit from mechanical thrombectomy in the 6-24 hour time window. European Stroke Journal. https://doi.org/10.1177/23969873241239208

Goeldlin, Martina B., Mueller, Madlaine, Siepen, Bernhard M., Zhang, Wenpeng, Ozkan, Hatice, Locatelli, Martina, Du, Yang, Valenzuela, Waldo, Radojewski, Piotr, Hakim, Arsany, Kaesmacher, Johannes, Meinel, Thomas R., Clénin, Leander, Branca, Mattia, Strambo, Davide, Fischer, Tim, Medlin, Friedrich, Peters, Nils, Carrera, Emmanuel, et al. (2024). CADMUS: A Novel MRI-Based Classification of Spontaneous Intracerebral Hemorrhage Associated With Cerebral Small Vessel Disease. Neurology, 102. https://doi.org/10.1212/wnl.0000000000207977

Kriemler, Lilian, Rudin, Salome, Gawinecka, Joanna, Gross, Felix, Arnold, Markus, Schweizer, Juliane, Westphal, Laura, Inauen, Corinne, Pokorny, Thomas, Dittrich, Tolga, Toebak, Anna, Arnold, Marcel, Christ-Crain, Mirjam, von Eckardstein, Arnold, Rentsch, Katharina, Katan, Mira, & De Marchis, Gian Marco. (2024). Discordance between LDL-C and apolipoprotein B is associated with large-artery-atherosclerosis ischemic stroke in patients ⩽70 years of age. European Stroke Journal, 9, 494–500. https://doi.org/10.1177/23969873231221619

Siepen, Bernhard M., Forfang, Elisabeth, Branca, Mattia, Drop, Boudewijn, Mueller, Madlaine, Goeldlin, Martina B., Katan, Mira, Michel, Patrik, Cereda, Carlo, Medlin, Friedrich, Peters, Nils, Renaud, Susanne, Niederhauser, Julien, Carrera, Emmanuel, Kahles, Timo, Kägi, Georg, Bolognese, Manuel, Salmen, Stephan, Mono, Marie-Luise, et al. (2024). Intracerebral haemorrhage in patients taking different types of oral anticoagulants: a pooled individual patient data analysis from two national stroke registries. Stroke and Vascular Neurology. https://doi.org/10.1136/svn-2023-002813

Sporns, Peter B., Fischer, Urs, Katan, Mira, Ospel, Johanna M., Brehm, Alex, Tsogkas, Ioannis, Holodinsky, Jessalyn K., Kamal, Noreen, Fiehler, Jens, & Psychogios, Marios-Nikos. (2024). Simulation of transportation of acute stroke patients in border regions. Scientific Reports, 14. https://doi.org/10.1038/s41598-024-51959-y

Stefanou, Maria-Ioanna, Theodorou, Aikaterini, Malhotra, Konark, Aguiar de Sousa, Diana, Katan, Mira, Palaiodimou, Lina, Katsanos, Aristeidis H, Koutroulou, Ioanna, Lambadiari, Vaia, Lemmens, Robin, Giannopoulos, Sotirios, Alexandrov, Andrei V, Siasos, Gerasimos, & Tsivgoulis, Georgios. (2024). Risk of major adverse cardiovascular events and stroke associated with treatment with GLP-1 or the dual GIP/GLP-1 receptor agonist tirzepatide for type 2 diabetes: A systematic review and meta-analysis. European Stroke Journal, null. https://doi.org/10.1177/23969873241234238

Zietz, A., Gorey, S., Kelly, P. J., Katan, M., & McCabe, J. J. (2024). Targeting inflammation to reduce recurrent stroke. International Journal of Stroke, 19, 379–387. https://doi.org/10.1177/17474930231207777

Cameron, A., Arnold, M., Katsas, G., Yang, J., Quinn, T. J., Abdul-Rahim, A. H., Campbell, R., Docherty, K., De Marchis, G. M., Arnold, M., Kahles, T., Nedeltchev, K., Cereda, C., Kaegi, G., Bustamante, A., Montaner, J., Ntaios, G., Foerch, C., Spanaus, K., et al. (2023). Natriuretic Peptides Improve Classification of People at Low Risk of Atrial Fibrillation after Stroke [Posted-content]. Cold Spring Harbor Laboratory. https://doi.org/10.1101/2023.09.28.23296282

Schulze-Zachau V, Brehm A, Ntoulias N, Krug N, Tsogkas I, Blackham KA, Möhlenbruch MA, Jesser J, Cervo A, Kreiser K, Althaus K, Maslias E, Michel P, Saliou G, Riegler C, Nolte CH, Maier I, Jamous A, Rautio R, et al. (2023). Incidence and outcome of perforations during medium vessel occlusion compared with large vessel occlusion thrombectomy. Journal of Neurointerventional Surgery. https://doi.org/10.1136/jnis-2023-020531

Arnold M, Kaesmacher J, & Katan M. (2023). How to Keep Your (Stroke) Trial Alive? Stroke, 54(4), e167–e170. https://doi.org/10.1161/strokeaha.122.037784

Seystahl K, Schweizer J, Katan M, Weber SJ, Hug A, Wanner M, Luft AR, Rohrmann S, Wegener S, & Weller M. (2023). Stroke-associated infections in patients with and without cancer. Neuro-Oncology Practice, 10(2), 176–185. https://doi.org/10.1093/nop/npac075

Cameron, Alan C., Katsas, Georgios, Arnold, Markus, Docherty, Kieran, Campbell, Ross T., Murdoch, David, McClure, John D., Katan, Mira, Lip, Gregory Y.H., Abdul-Rahim, Azmil H., & Dawson, Jesse. (2023). Preventing Recurrent Cardioembolic Stroke: Right Approach, Right Patient (PRECISE) Study Protocol. Cerebrovascular Diseases, 52, 123–129. https://doi.org/10.1159/000525918

Dittrich, Tolga D, Aujesky, Mara, Rudin, Salome, Zietz, Annaelle, Wagner, Benjamin, Polymeris, Alexandros, Altersberger, Valerian L, Sinnecker, Tim, Gensicke, Henrik, Engelter, Stefan T, Lyrer, Philippe, Hess, Viviane, Sutter, Raoul, Nickel, Christian H, Bonati, Leo H, Fischer, Urs, Psychogios, Marios, Katan, Mira, & De Marchis, Gian Marco. (2023). Apical pulmonary lesions suspected of malignancy visible on neck CT angiography performed for acute stroke: Prevalence, treatment, and clinical implications - the PLEURA study. European Stroke Journal, 8(2), 549–556. https://doi.org/10.1177/23969873231151488

Dittrich, Tolga D, Aujesky, Mara, Rudin, Salome, Zietz, Annaelle, Wagner, Benjamin, Polymeris, Alexandros, Altersberger, Valerian L, Sinnecker, Tim, Gensicke, Henrik, Engelter, Stefan T, Lyrer, Philippe, Hess, Viviane, Sutter, Raoul, Nickel, Christian H, Bonati, Leo H, Fischer, Urs, Psychogios, Marios, Katan, Mira, & De Marchis, Gian Marco. (2023). Apical pulmonary lesions suspected of malignancy visible on neck CT angiography performed for acute stroke: Prevalence, treatment, and clinical implications – the PLEURA study. European Stroke Journal, 8, 549–556. https://doi.org/10.1177/23969873231151488

Dittrich, Tolga D, Sporns, Peter B, Kriemler, Lilian F, Rudin, Salome, Nguyen, Anh, Zietz, Annaelle, Polymeris, Alexandros A, Tränka, Christopher, Thilemann, Sebastian, Wagner, Benjamin, Altersberger, Valerian L, Piot, Ines, Barinka, Filip, Hänsel, Martin, Gensicke, Henrik, Engelter, Stefan T, Lyrer, Philippe A, Sutter, Raoul, Nickel, Christian H, et al. (2023). Mechanical thrombectomy for large vessel occlusion between 6 and 24 h: outcome comparison of DEFUSE-3/DAWN eligible versus non-eligible patients. International Journal of Stroke, 18, 697–703. https://doi.org/10.1177/17474930221140793

Dittrich, Tolga D., Sporns, Peter B., Kriemler, Lilian F., Rudin, Salome, Nguyen, Anh, Zietz, Annaelle, Polymeris, Alexandros A., Tränka, Christopher, Thilemann, Sebastian, Wagner, Benjamin, Altersberger, Valerian L., Piot, Ines, Barinka, Filip, Müller, Susanne, Hänsel, Martin, Gensicke, Henrik, Engelter, Stefan T., Lyrer, Philippe A., Sutter, Raoul, et al. (2023). Mechanical Thrombectomy Versus Best Medical Treatment in the Late Time Window in Non-DEFUSE-Non-DAWN Patients: A Multicenter Cohort Study. Stroke, 54, 722–730. https://doi.org/10.1161/strokeaha.122.039793

Dittrich, Tolga D, Sporns, Peter B, Kriemler, Lilian F, Rudin, Salome, Nguyen, Anh, Zietz, Annaelle, Polymeris, Alexandros A, Tränka, Christopher, Thilemann, Sebastian, Wagner, Benjamin, Altersberger, Valerian L, Piot, Ines, Barinka, Filip, Müller, Susanne, Hänsel, Martin, Gensicke, Henrik, Engelter, Stefan T, Lyrer, Philippe A, Sutter, Raoul, et al. (2023). Mechanical Thrombectomy Versus Best Medical Treatment in the Late Time Window in Non-DEFUSE-Non-DAWN Patients: A Multicenter Cohort Study. Stroke, EPUB ahead of print. https://doi.org/10.1161/strokeaha.122.039793

Honegger, Tim, Schweizer, Juliane, Bicvic, Antonela, Westphal, Laura P, Schütz, Valerie, Inauen, Corinne, Pokorny, Thomas, Bracher, Katja, Arnold, Marcel, Fischer, Urs, Bonati, Leo H, De Marchis, Gian Marco, Nedeltchev, Krassen, Kahles, Timo, Cereda, Carlo, Kägi, Georg, Montaner, Joan, Bustamante, Alejandro, Palà, Elena, et al. (2023). Serum S-100B adds incremental value for the prediction of symptomatic intracranial hemorrhage and brain edema after acute ischemic stroke. European Stroke Journal, 8, 309–319. https://doi.org/10.1177/23969873221145391

Schütz, Valerie, Dougoud, Svetlana, Bracher, Katja, Arnold, Markus, Schweizer, Juliane, Nakas, Christos, Westphal, Laura P., Inauen, Corinne, Pokorny, Thomas, Duru, Firat, Steffel, Jan, Luft, Andreas, Spanaus, Katharina, Saguner, Ardan Muammer, & Katan, Mira. (2023). The Role of Electrocardiographic Markers for Predicting Atrial Fibrillation in Patients with Acute Ischemic Stroke: Data from the BIOSIGNAL Cohort Study. Journal of Clinical Medicine, 12. https://doi.org/10.3390/jcm12216830

Silimon, Norbert, Drop, Boudewijn, Clénin, Leander, Nedeltchev, Krassen, Kahles, Timo, Tarnutzer, Alexander A, Katan, Mira, Bonati, Leo, Salmen, Stephan, Albert, Sylvan, Salerno, Alexander, Carrera, Emmanuel, Berger, Christian, Peters, Nils, Medlin, Friedrich, Cereda, Carlo, Bolognese, Manuel, Kägi, Georg, Renaud, Susanne, et al. (2023). Ischaemic stroke despite antiplatelet therapy: Causes and outcomes. European Stroke Journal, 8, 692–702. https://doi.org/10.1177/23969873231174942

Sinka, Lucia, Abraira, Laura, Imbach, Lukas L., Zieglgänsberger, Dominik, Santamarina, Estevo, Álvarez-Sabín, José, Ferreira-Atuesta, Carolina, Katan, Mira, Scherrer, Natalie, Bicciato, Giulio, Terziev, Robert, Simmen, Cyril, Schubert, Kai Michael, Elshahabi, Adham, Baumann, Christian R., Döhler, Nico, Erdélyi-Canavese, Barbara, Felbecker, Ansgar, Siebel, Philip, et al. (2023). Association of Mortality and Risk of Epilepsy with Type of Acute Symptomatic Seizure after Ischemic Stroke and an Updated Prognostic Model. JAMA Neurology, 80, 605–613. https://doi.org/10.1001/jamaneurol.2023.0611

Ward, Kirsty, Vail, Andy, Cameron, Alan, Katan, Mira, Lip, Gregory YH, Dawson, Jesse, Smith, Craig J, & Kishore, Amit K. (2023). Molecular biomarkers predicting newly detected atrial fibrillation after ischaemic stroke or TIA: A systematic review. European Stroke Journal, 8, 125–131. https://doi.org/10.1177/23969873221136927

Zietz, Annaelle, Polymeris, Alexandros A, Helfenstein, Fabrice, Schaedelin, Sabine, Hert, Lisa, Wagner, Benjamin, Seiffge, David J, Traenka, Christopher, Altersberger, Valerian L, Dittrich, Tolga, Kaufmann, Josefin, Ravanelli, Flavia, Fladt, Joachim, Fisch, Urs, Thilemann, Sebastian, De Marchis, Gian Marco, Gensicke, Henrik, Bonati, Leo H, Katan, Mira, et al. (2023). The impact of competing stroke etiologies in patients with atrial fibrillation. European Stroke Journal, 8, 703–711. https://doi.org/10.1177/23969873231185220

Thomas R Meinel, Duncan Wilson, Henrik Gensicke, Jan F Scheitz, Peter Ringleb, Ioana Goganau, Johannes Kaesmacher, Hee-Joon Bae, Do Yeon Kim, Pawel Kermer, Kentaro Suzuki, Kazumi Kimura, Kosmas Macha, Masatoshi Koga, Shinichi Wada, Valerian Altersberger, Alexander Salerno, Logesh Palanikumar, Andrea Zini, et al. (2023). Intravenous Thrombolysis in Patients With Ischemic Stroke and Recent Ingestion of Direct Oral Anticoagulants. JAMA Neurology.

Inauen C., Boss J.M., Katan M., Luft A.R., Kulcsar Z., Willms J.F., Bogli S.Y., & Keller E. (2022). Blood Pressure Variability Indices for Outcome Prediction After Thrombectomy in Stroke by Using High-Resolution Data. Neurocritical Care, 37, 220–229. https://doi.org/10.1007/s12028-022-01519-x

Bicvic A, Scherrer N, Schweizer J, Fluri F, Christ-Crain M, De Marchis GM, Luft AR, & Katan M. (2022). A novel biomarker panel index improves risk stratification after ischemic stroke. European Stroke Journal, 7(2), 158–165. https://doi.org/10.1177/23969873221090798

Polymeris AA, Meinel TR, Oehler H, Hölscher K, Zietz A, Scheitz JF, Nolte CH, Stretz C, Yaghi S, Stoll S, Wang R, Häusler KG, Hellwig S, Klammer MG, Litmeier S, Leon Guerrero CR, Moeini-Naghani I, Michel P, Strambo D, et al. (2022). Aetiology, secondary prevention strategies and outcomes of ischaemic stroke despite oral anticoagulant therapy in patients with atrial fibrillation. Journal of Neurology, Neurosurgery, and Psychiatry, 93(6), 588–598. https://doi.org/10.1136/jnnp-2021-328391

Schweizer J, Arnold M, König IR, Bicvic A, Westphal LP, Schütz V, Inauen C, Scherrer N, Luft A, Galovic M, Ferreira Atuesta C, Pokorny T, Arnold M, Fischer U, Bonati LH, De Marchis GM, Kahles T, Nedeltchev K, Cereda CW, et al. (2022). Measurement of Midregional Pro-Atrial Natriuretic Peptide to Discover Atrial Fibrillation in Patients With Ischemic Stroke. Journal of the American College of Cardiology, 79(14), 1369–1381. https://doi.org/10.1016/j.jacc.2022.01.042

Bicciato G., Arnold M., Gebhardt A., & Katan M. (2022). Precision medicine in secondary prevention of ischemic stroke: how may blood-based biomarkers help in clinical routine? An expert opinion. Current Opinion in Neurology, 35(1), 45–54. https://doi.org/10.1097/wco.0000000000001011

Du Fay De Lavallaz, Jeanne, Prepoudis, Alexandra, Wendebourg, Maria Janina, Kesenheimer, Eva, Kyburz, Diego, Daikeler, Thomas, Haaf, Philip, Wanschitz, Julia, Löscher, Wolfgang N., Schreiner, Bettina, Katan, Mira, Jung, Hans H., Maurer, Britta, Hammerer-Lercher, Angelika, Mayr, Agnes, Gualandro, Danielle M., Acket, Annemarie, Puelacher, Christian, Boeddinghaus, Jasper, et al. (2022). Skeletal Muscle Disorders: A Noncardiac Source of Cardiac Troponin T. Circulation, 145, 1764–1779. https://doi.org/10.1161/circulationaha.121.058489

Liberale, Luca, Ministrini, Stefano, Arnold, Markus, Puspitasari, Yustina M., Pokorny, Thomas, Beer, Georgia, Scherrer, Natalie, Schweizer, Juliane, Christ-Crain, Mirjam, Montecucco, Fabrizio, Camici, Giovanni G., & Katan Kahles, Mira. (2022). Serum circulating sirtuin 6 as a novel predictor of mortality after acute ischemic stroke. Scientific Reports, 12. https://doi.org/10.1038/s41598-022-23211-y

Alan C Camero, , Georgios Katsas, Markus Arnold, Kieran Docherty, Ross T Campbell, David Murdoch, John D McClure, Mira Katan, Gregory YH Lip, Azmil H Abdul-Rahim, & Jesse Dawson. (2022). Preventing Recurrent Cardioembolic Stroke: Right Approach, Right Patient (PRECISE) Study Protocol. Cerebrovascular Diseases, 7. https://doi.org/10.1159/000525918

Katharina Seystahl, Juliane Schweizer, Mira Katan, Sung Ju Weber, Alessia Hug, Miriam Wanner, Andreas R Luft, Sabine Rohrmann, Susanne Wegener, & Michael Weller. (2022). Stroke-associated infections in patients with and without cancer. Neuro-Oncology Practice. https://doi.org/10.1093/nop/npac075

Kirsty Ward, Andy Vail, Alan Cameron, Mira Katan, Gregory YH Lip, Jesse Dawson, Craig J Smith, & Amit K Kishore. (2022). Molecular biomarkers predicting newly detected atrial fibrillation after ischemic stroke or TIA: A systematic review. European Stroke Journal. https://doi.org/10.1177/23969873221136927

Luca Liberale, Stefano Ministrini, Markus Arnold, Yustina M Puspitasari, Thomas Pokorny, Georgia Beer, Natalie Scherrer, Juliane Schweizer, Mirjam Christ-Crain, Fabrizio Montecucco, Giovanni G Camici, & Mira Katan Kahles. (2022). Serum circulating sirtuin 6 as a novel predictor of mortality after acute ischemic stroke. Scientific Reports, 12(1), 8. https://www.nature.com/articles/s41598-022-23211-y

S Ministrini, L Liberale, G Beer, YM Puspitasari, L Schwarz, R Niederberger, M Katan Kahles, M Bacigaluppi, A Akhmedov, F Montecucco, TF Luescher, & GG Camici. (2022). Endothelial expression of JCAD worsens outcome after acute ischemic stroke: a translational study. European Heart Journal, 32, 1. https://doi.org/10.1093/eurheartj/ehac544.1993

Tolga Daniel Dittrich, Peter Sporns, Lilian Kriemler, Salome Rudin, Anh Nguyen, Annaelle Zietz, Alexandros A Polymeris, Christopher Tränka, Sebastian Thilemann, Benjamin Wagner, Valerian Altersberger, Ines Piot, Filip Barinka, Martin Hänsel, Henrik Gensicke, Stefan Engelter, Philippe A Lyrer, Raoul Sutter, Christian Nickel, et al. (2022). Mechanical Thrombectomy For Large Vessel Occlusion Between 6 And 24 Hours: Outcome Comparison Of Defuse-3/Dawn Eligible Versus Non-Eligible Patients. International Journal of Stroke. https://doi.org/10.1177/17474930221140793

Ferreira-Atuesta C., Dohler N., Erdelyi-Canavese B., Felbecker A., Siebel P., Scherrer N., Bicciato G., Schweizer J., Sinka L., Imbach L.L., Katan M., Abraira L., Santamarina E., Alvarez-Sabin J., Winklehner M., von Oertzen T.J., Wagner J.N., Gigli G.L., Serafini A., et al. (2021). Seizures after Ischemic Stroke: A Matched Multicenter Study. Annals of Neurology, 90(5), 808–820. https://doi.org/10.1002/ana.26212

Seystahl K., Hug A., Weber S.J., Kapitza S., Gramatzki D., Wanner M., Katan M., Luft A.R., Rohrmann S., Wegener S., & Weller M. (2021). Cancer is associated with inferior outcome in patients with ischemic stroke. Journal of Neurology, 268(11), 4190–4202. https://doi.org/10.1007/s00415-021-10528-3

Katan M., & Wegener S. (2021). Secondary prevention of ischemic stroke: Laboratory and imaging biomarkers Sekundärprävention des Hirnschlags: Laborchemische und bildgebende Biomarker beim ischämischen Schlaganfall. Therapeutische Umschau, 78(6), 291–298. https://doi.org/10.1024/0040-5930/a001273

Arnold M, Schweizer J, Nakas CT, Schütz V, Westphal LP, Inauen C, Pokorny T, Luft A, Leichtle A, Arnold M, Bicvic A, Fischer U, De Marchis GM, Bonati LH, Müller MD, Kahles T, Nedeltchev K, Cereda CW, Kägi G, et al. (2021). Lipoprotein(a) is associated with large artery atherosclerosis stroke aetiology and stroke recurrence among patients below the age of 60 years: results from the BIOSIGNAL study. European Heart Journal, 42(22), 2186–2196. https://doi.org/10.1093/eurheartj/ehab081

Gil L.A., Krattinger-Turbatu L., Schweizer J., Katan M., & Sanchez J.-C. (2021). A panel comprising serum amyloid a, white blood cells and nihss for the triage of patients at low risk of post-stroke infection. Diagnostics, 11(6). https://doi.org/10.3390/diagnostics11061070

Arnold M., Gill D., & Katan M. (2021). A Good Start to Shed More Light on the Relationship Between Glycemic Traits, Diabetes Mellitus, and Cerebrovascular Disease. Neurology, 96(13), 602–603. https://doi.org/10.1212/wnl.0000000000011557

Markus, A., Valerie, S., & Mira, K. (2021). Promising Biomarker Candidates for Cardioembolic Stroke Etiology. A Brief Narrative Review and Current Opinion. Frontiers in Neurology, 12. https://doi.org/10.3389/fneur.2021.624930

Westphal L.P., Schweizer J., Fluri F., De Marchis GM, Christ-Crain M, Luft A.R., & Katan M. (2021). C-Terminal-Pro-Endothelin-1 Adds Incremental Prognostic Value for Risk Stratification After Ischemic Stroke. Frontiers in Neurology, 11. https://doi.org/10.3389/fneur.2020.629151

Aguiar De Sousa D., & Katan M. (2021). Promising Use of Automated Electronic Phenotyping: Turning Big Data Into Big Value in Stroke Research. Stroke, 52(1), 190–192. https://doi.org/10.1161/strokeaha.120.033061

de Sousa, D.A., Chun, Y., & Katan, M. (2021). Joint European & World Stroke Organisation (ESO-WSO) Conference Highlights-2020. Clinical and Translational Neuroscience.

Hotter B., Hoffmann S., Ulm L., Meisel C., Bustamante A., Montaner J., Katan M., Smith C.J., & Meisel A. (2021). External Validation of Five Scores to Predict Stroke-Associated Pneumonia and the Role of Selected Blood Biomarkers. Stroke, 52(1), 325–330. https://doi.org/10.1161/strokeaha.120.031884

Meinel T.R., Branca M., De Marchis GM, Nedeltchev K, Kahles T, Bonati L, Arnold M, Heldner MR, Jung S., Carrera E., Dirren E., Michel P, Strambo D., Cereda C.W., Bianco G., Kägi G, Vehoff J., Katan M., Bolognese M., et al. (2021). Prior Anticoagulation in Patients with Ischemic Stroke and Atrial Fibrillation. Annals of Neurology, 89(1), 42–53. https://doi.org/10.1002/ana.25917

Gutierrez, J., Katan, M., & Elkind, M. S. V.. (2021). Inflammatory and Infectious Vasculopathies. In Stroke: Pathophysiology, Diagnosis, and Management.

Schweizer J., Bustamante A., Lapierre-Fetaud V., Faura J., Scherrer N., Azurmendi Gil L., Fluri F., Schutz V., Luft A., Boned S., Sanchez J.-C., Montaner J., & Katan M. (2020). SAA (Serum Amyloid A): A Novel Predictor of Stroke-Associated Infections. Stroke, 51(12), 3523–3530. https://doi.org/10.1161/strokeaha.120.030064

Arnold M., Nakas C, Luft A, Christ-Crain M, Leichtle A, & Katan M. (2020). Independent Prognostic Value of MRproANP (Midregional Proatrial Natriuretic Peptide) Levels in Patients With Stroke Is Unaltered Over Time. Stroke, 51(6), 1873–1875. https://doi.org/10.1161/strokeaha.120.029333

Gruber P., Fluri F., Schweizer J., Luft A., Müller B, Christ-Crain M, & Katan M. (2020). Proenkephalin A Adds No Incremental Prognostic Value After Acute Ischemic Stroke. Clinical and Applied Thrombosis/Hemostasis, 26. https://doi.org/10.1177/1076029619895318

Valérie Schütz, & Mira Katan. (2020). Ursachenabklärung des ischämischen Schlaganfalls – eine spannende Herausforderung. LEADING OPINIONT Neurologie & Psychiatrie. https://www.universimed.com/at/article/neurologie/ursachenabklaerung-schlaganfalls-2272928

Kishore A.K., Jeans A.R., Garau J., Bustamante A., Kalra L., Langhorne P., Chamorro A., Urra X., Katan M., Napoli M.D., Westendorp W., Nederkoorn P.J., van de Beek D., Roffe C., Woodhead M., Montaner J., Meisel A., & Smith C.J. (2019). Antibiotic treatment for pneumonia complicating stroke: Recommendations from the pneumonia in stroke consensus (PISCES) group. European Stroke Journal, 4(4), 318–328. https://doi.org/10.1177/2396987319851335

Sandset EC, de Sousa DA, Christensen H., Cordonnier C., Fischer U, Katan M., Kremer C, Pavlovic A, Sprigg N, Bart van der Worp H, Zedde M, & Caso V. (2019). Women in the European Stroke Organisation: One, two, many… – A Top Down and Bottom Up approach. European Stroke Journal, 4(3), 247–253. https://doi.org/10.1177/2396987319841979

Loch Macdonald R., & Katan M. (2019). Haptoglobin and hemoglobin in subarachnoid hemorrhage A tale of 2 globins. Neurology, 92(18), 831–832. https://doi.org/10.1212/wnl.0000000000007399

Katan M., & Lubitz S.A. (2019). ECG monitoring after acute ischemic stroke: Does patient selection matter? Neurology, 92(2), 65–66. https://doi.org/10.1212/wnl.0000000000006719

De Marchis, Gian Marco, Dankowski, Theresa, König, Inke R., Fladt, Joachim, Fluri, Felix, Gensicke, Henrik, Foerch, Christian, Findling, Oliver, Kurmann, Rebekka, Fischer, Urs, Luft, Andreas, Buhl, Daniela, Engelter, Stefan T., Lyrer, Philippe A., Christ-Crain, Mirjam, Christ-Crain, Mirjam, Arnold, Marcel, & Katan, Mira. (2019). A novel biomarker-based prognostic score in acute ischemic stroke: The CoRisk score. Neurology, 92(13), e1517–e1525. https://doi.org/10.1212/wnl.0000000000007177

De Marchis GM, Garcia-Berrocoso T., Elkind M.S.V., & Katan M. (2018). Incorporating Biomarkers Into a Stroke Research Career. Stroke, 49(12), e329–e331. https://doi.org/10.1161/strokeaha.118.022915

Katan M., & Luft A. (2018). Global Burden of Stroke. Seminars in Neurology, 38(2), 208–211. https://doi.org/10.1055/s-0038-1649503

De Marchis, Gian Marco, Katan, Mira, Barro, Christian, Fladt, Joachim, Traenka, Christopher, Seiffge, David J., Hert, Lisa, Gensicke, Henrik, Disanto, Giulio, Sutter, Raoul, Peters, Nils, Sarikaya, Hakan, Goeggel-Simonetti, Barbara, El-Koussy, Marwan, Engelter, Stephan, Lyrer, Philippe A., Christ-Crain, Mirjam, Arnold, Marcel, Kuhle, Jens, & Bonati, Leo H. (2018). Serum neurofilament light chain in patients with acute cerebrovascular events. European Journal of Neurology, 25(3), 562–568. https://doi.org/10.1111/ene.13554

De Marchis, Gian Marco, Schneider, Juliane, Weck, Anja, Fluri, Felix, Fladt, Joachim, Foerch, Christian, Mueller, Beat, Luft, Andreas, Christ-Crain, Mirjam, Arnold, Marcel, & Katan, Mira. (2018). Midregional proatrial natriuretic peptide improves risk stratification after ischemic stroke. Neurology, 90, e455–e465. https://doi.org/10.1212/wnl.0000000000004922

Wegener S., & Katan M. (2018). Getting the First Grant. Stroke, 49(1). https://doi.org/10.1161/strokeaha.117.019897

Mira Katan, & Mitchell SV Elkind. (2018). The potential role of blood biomarkers in patients with ischemic stroke: An expert opinion. Clinical and Transitional Neuroscience, 2. https://doi.org/10.1177/2514183X18768050

Hotter B., Ulm L., Hoffmann S., Katan M., Montaner J., Bustamante A., & Meisel A. (2017). Selection bias in clinical stroke trials depending on ability to consent. BMC Neurology, 17(1). https://doi.org/10.1186/s12883-017-0989-9

Schmidt A., Katan M., & Sandset E.C. (2017). Why Is It Worthwhile to Get Involved in Stroke Organizations? Stroke, 48(10), e277–e279. https://doi.org/10.1161/strokeaha.117.018850

Scherrer N, Fays F, Mueller B, Luft A, Fluri F, Christ-Crain M, Devaux Y, & Katan M. (2017). Microrna 150-5p improves risk classification for mortality within 90 days after acute ischemic stroke. Journal of Stroke, 19(3), 323–332. https://doi.org/10.5853/jos.2017.00423

Li Z., & Katan M. (2017). Coming to the United States for a Stroke Research Fellowship. Stroke, 48(8), e190–e192. https://doi.org/10.1161/strokeaha.117.018084

Azurmendi L., Lapierre-Fetaud V., Schneider J., Montaner J., Katan M., & Sanchez J.-C. (2017). Proteomic discovery and verification of serum amyloid A as a predictor marker of patients at risk of post-stroke infection: A pilot study. Clinical Proteomics, 14(1). https://doi.org/10.1186/s12014-017-9162-0

Ulm L., Hoffmann S., Nabavi D., Hermans M., Mackert B.-M., Hamilton F., Schmehl I., Jungehuelsing G.-J., Montaner J., Bustamante A., Katan M., Hartmann A., Ebmeyer S., Dinter C., Wiemer J.C., Hertel S., Meisel C., Anker S.D., & Meisel A. (2017). The randomized controlled STRAWINSKI trial: Procalcitonin-guided antibiotic therapy after stroke. Frontiers in Neurology, 8(APR). https://doi.org/10.3389/fneur.2017.00153

Bustamante A., Vilar-Bergua A., Guettier S., Sanchez-Poblet J., Garcia-Berrocoso T., Giralt D., Fluri F., Topakian R., Worthmann H., Hug A., Molnar T., Waje-Andreassen U., Katan M., Smith C.J., & Montaner J. (2017). C-reactive protein in the detection of post-stroke infections: systematic review and individual participant data analysis. Journal of Neurochemistry, 141(2), 305–314. https://doi.org/10.1111/jnc.13973

Katan M., Moon Y., Von Eckardstein A., Spanaus K., Derosa J., Gutierrez J., Decarli C., Wright C., Sacco R., & Elkind M. (2017). Procalcitonin and Midregional Proatrial Natriuretic Peptide as Biomarkers of Subclinical Cerebrovascular Damage: The Northern Manhattan Study. Stroke, 48(3), 604–610. https://doi.org/10.1161/strokeaha.116.014945

Blum, Claudine Angela, Winzeler, Bettina, Nigro, Nicole, Schuetz, Philipp, Biethahn, Silke, Kahles, Timo, Müller, Cornelia, Timper, Katharina, Haaf, Katharina, Tepperberg, Janina, Amort, Margareth, Huber, Andreas, Bingisser, Roland, Sándor, Peter Stephan, Nedeltchev, Krassen, Müller, Beat, Katan, Mira, & Christ-Crain, Mirjam. (2017). Copeptin for risk stratification in non-traumatic headache in the emergency setting: a prospective multicenter observational cohort study. Journal of Headache and Pain, 18(1), 21. https://doi.org/10.1186/s10194-017-0733-2

Kelly P.J., Albers G.W., Chatzikonstantinou A., De Marchis,Gian Marco, Ferrari J., George P., Katan M., Knoflach M., Kim J.S., Li,Linxin, Lee E.-J., Olivot J.-M., Purroy F., Raposo N., Rothwell P.M., Sharma V.K., Song B., Tsivgoulis G., Walsh C., et al. (2016). Validation and comparison of imaging-based scores for prediction of early stroke risk after transient ischaemic attack: a pooled analysis of individual-patient data from cohort studies. The Lancet Neurology, 15(12), 1238–1247. https://doi.org/10.1016/s1474-4422(16)30236-8

Katan, M., Moon, Y. P., Paik, M. C., Müller, B., Huber, A., Sacco, R. L., & Elkind, M. S. (2016). Procalcitonin and Midregional Proatrial Natriuretic Peptide as Markers of Ischemic Stroke: The Northern Manhattan Study. Stroke, 47(7), 1714–1719. https://doi.org/10.1161/strokeaha.115.011392

Urwyler, Sandrine Andrea, Timper, Katharina, Fenske, Wiebke, de Mota, Nadia, Blanchard, Anne, Kühn, Felix, Frech, Nica, Arici, Birsen, Rutishauser, Jonas, Kopp, Peter, Stettler, Christoph, Müller, Beat, Katan, Mira, Llorens-Cortes, Catherine, & Christ-Crain, Mirjam. (2016). Plasma Apelin Concentrations in Patients With Polyuria-Polydipsia Syndrome. The Journal of Clinical Endocrinology and Metabolism, 101(5), 1917–1923. https://doi.org/10.1210/jc.2016-1158

Gutierrez J., Katan M., & Elkind M.S.V. (2015). Collagen Vascular and Infectious Diseases (pp. 619–631). Elsevier Inc. https://doi.org/10.1016/b978-0-323-29544-4.00036-0

Timper, K., Fenske, W., Kuhn, F., Frech, N., Arici, B., Rutishauser, J., Kopp, P., Allolio, B., Stettler, C., Muller, B., Katan, M., & Christ-Crain, M. (2015). Diagnostic Accuracy of Copeptin in the Differential Diagnosis of the Polyuria-polydipsia Syndrome: A Prospective Multicenter Study. Journal of Clinical Endocrinology and Metabolism, 100(6), 2268–2274. https://doi.org/10.1210/jc.2014-4507

Julian Sonderer, & Mira Katan Kahles. (2015). Aetiological blood biomarkers of ischaemic stroke. Swiss Med Weakly, 2122(145), 15. https://doi.org/10.4414/smw.2015.14138

Michael Varner, Mira Katan, & Kathleen Digree. (2015). Epilepsy and Pregnancy. Maternal Medicine. Mcgraw Hill Professional, 7.

Liebman, B. F., Katan, M. B., & Jacobson, M. F. (2014). To the editor. Annals of Internal Medicine, 161(6), 454–455. https://doi.org/10.7326/l14-5018-4

Frontzek K., Fluri F., Siemerkus J., Müller B, Gass A., Christ-Crain M, & Katan M. (2014). Isolated insular strokes and plasma MR-proANP levels are associated with newly diagnosed atrial fibrillation: A pilot study. PLoS ONE, 9(3). https://doi.org/10.1371/journal.pone.0092421

Katan M., Moon Y.P., Paik M.C., Wolfert R.L., Sacco R.L., & Elkind M.S.V. (2014). Lipoprotein-associated phospholipase A2 is associated with atherosclerotic stroke risk: The Northern Manhattan Study. PLoS ONE, 9(1). https://doi.org/10.1371/journal.pone.0083393

De Marchis, G. M., Weck, A., Audebert, H., Benik, S., Foerch, C., Buhl, D., Schuetz, P., Jung, S., Seiler, M., Morgenthaler, N. G., Mattle, H. P., Müller, B., Christ-Crain, M., Arnold, M., & Katan, M. (2014). Copeptin for the prediction of recurrent cerebrovascular events after transient ischemic attack: results from the CoRisk study. Stroke, 45(10), 2918–2923. https://doi.org/10.1161/strokeaha.114.005584

Fischer, M., Katan, M., Morgenthaler, N. G., Seiler, M., Muller, B., Lackner, P., Errath, M., Helbok, R., Pfausler, B., Beer, R., Schmutzhard, E., & Broessner, G. (2014). The prognostic value of midregional proatrial natriuretic peptide in patients with hemorrhagic stroke. Cerebrovascular Diseases, 37(2), 128–133. https://doi.org/10.1159/000357215

Nigro, N., Wildi, K., Müller, C., Schuetz, P., Müller, B., Fluri, F., Christ-Crain, M., & Katan, M. (2014). BNP but Not s-cTnln is associated with cardioembolic aetiology and predicts short and long term prognosis after cerebrovascular events. PLoS ONE, 9(7), e102704. https://doi.org/10.1371/journal.pone.0102704

Senn R, Elkind M.S.V., Montaner J, Christ-Crain M, & Katan M. (2014). Potential role of blood biomarkers in the management of nontraumatic intracerebral hemorrhage. Cerebrovascular Diseases, 38(6), 395–409. https://doi.org/10.1159/000366470

Timo, Kahles, & Mira, Katan. (2014). Copeptin and cerebrovascular disease. In Copeptin- Biochemistry and Clinical Diagnostics. UNI-MED.

Katan M., & Elkind M.S.V. (2013). Infectious burden and its role in cerebrovascular disease and cognitive impairment. Future Virology, 8(9), 833–836. https://doi.org/10.2217/fvl.13.74

De Marchis GM, Katan M., Weck A., Brekenfeld C., Mattle H.P., Buhl D, Müller B, Christ-Crain M., Christ-Crain M, & Arnold M. (2013). Copeptin and risk stratification in patients with ischemic stroke and transient ischemic attack: The CoRisk Study. International Journal of Stroke, 8(3), 214–218. https://doi.org/10.1111/j.1747-4949.2011.00762.x

Katan M., Moon Y.P., Paik M.C., Sacco R.L., Wright C.B., & Elkind M.S.V. (2013). Infectious burden and cognitive function: The Northern Manhattan Study. Neurology, 80(13), 1209–1215. https://doi.org/10.1212/wnl.0b013e3182896e79

Fung C., De Marchis GM, Katan M., Seiler M., Arnold M, Gralla J., Raabe A., & Beck J. (2013). Copeptin as a Marker for Severity and Prognosis of Aneurysmal Subarachnoid Hemorrhage. PLoS ONE, 8(1). https://doi.org/10.1371/journal.pone.0053191

Blum, C. A., Müller, C., Schuetz, P., Fluri, F., Trummler, M., Müller, B., Katan, M., & Christ-Crain, M. (2013). Prognostic value of dehydroepiandrosterone-sulfate and other parameters of adrenal function in acute ischemic stroke. PLoS ONE, 8(5), e63224. https://doi.org/10.1371/journal.pone.0063224

De Marchis, G. M., Katan, M., Weck, A., Fluri, F., Foerch, C., Findling, O., Schuetz, P., Buhl, D., El-Koussy, M., Gensicke, H., Seiler, M., Morgenthaler, N., Mattle, H. P., Müller, B., Christ-Crain, M., & Arnold, M. (2013). Copeptin adds prognostic information after ischemic stroke: results from the CoRisk study. Neurology, 80(14), 1278–1286. https://doi.org/10.1212/wnl.0b013e3182887944

Fluri F, Jax F., Amort M, Wetzel SG, Lyrer PA, Katan M., Hatz F, & Engelter ST. (2012). Significance of microbleeds in patients with transient ischaemic attack. European Journal of Neurology, 19(3), 522–524. https://doi.org/10.1111/j.1468-1331.2011.03522.x

Engelter ST, Amort M., Jax F., Weisskopf F., Katan M., Burow A., Bonati LH, Hatz F, Wetzel SG, Fluri F., & Lyrer PA. (2012). Optimizing the risk estimation after a transient ischaemic attack - The ABCDE⊕ score. European Journal of Neurology, 19(1), 55–61. https://doi.org/10.1111/j.1468-1331.2011.03428.x

Fluri, F., Morgenthaler, N. G., Müller, B., Christ-Crain, M., & Katan, M. (2012). Copeptin, procalcitonin and routine inflammatory markers-predictors of infection after stroke. PLoS ONE, 7(10), e48309. https://doi.org/10.1371/journal.pone.0048309